Navigation Links
Biotech Osiris to go public

Baltimore biotech, the company that is known for being the sole manufacturer of the stem cell product, has made its plans known, about its intention to go public//. The company is slated to sell out nearly $80 million in shares, as per the papers filed with the Securities and Exchange Commission.

Stem cells have been under a lot of scrutiny, and debates have been raging about what this science can really offer. Controversy has always surrounded this area of research and morality issues about stem cells being extracted from human embryos have been clashing with scientific issues. This has led the federal government to reduce major funding of embryonic stem cell research.


'"/>




Page: 1

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Vical Biotech and NIH jointly develops HIV vaccine
9. Biotechnology Initiatives Planned In Hyderabad
10. Western Region Tops in Indian Biotech Growth
11. Pediatric Dengue Vaccine Initiative and Hawaii Biotech Partner Against Dengue Fever
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech Osiris public

(Date:10/7/2008)...recommendations reflect previously published ACSM/... /PRNewswire-USNewswire/ -- Guidelines,for physica...f Health and,Human Services (HHS) were met with su... (ACSM) and the American Heart Association (AHA). ...l activity recommendations,last year, attended tod...
(Date:10/7/2008)...NGTON, Oct. 7 /PRNewswire-USNewswire/ -- Kristi Ya...ner of Dancing With the Stars, has been,named chai...istmas Seals,Campaign in an effort to help raise f...prevent lung disease and promote lung health., Th...ion began in 1907,to conquer Tuberculosis. Today, ...
(Date:10/7/2008)...ly to feel distress, more likely to enjoy better q... Oct. 7 (HealthDay News) -- End-of-life discussion... not result in more distress for patients. In fact...ions and enhanced quality of life in a patient,s f... past two decades, the debate has been around when...
(Date:10/7/2008)...se announcement of planned bequest comes at stem c...re-USNewswire/ -- Just over one year,ago, retail p...ift to the,University of Michigan, to endow a new ...g and preventing human disease., Today, at the in...uncing that he will bequeath an additional $22 mil...
Breaking Medicine News(10 mins):Health News:ACSM, AHA Support Federal Physical Activity Guidelines 2Health News:ACSM, AHA Support Federal Physical Activity Guidelines 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 3Health News:Alfred Taubman Announces New $22M Gift to U-M 2
...certain chemicals has been known to be associated ...etc. from time immemorial. But it is known not unt...eased // following occupational exposure to minera...matiod factor remains unestablished. However, a nu...
...w kind of rat that will help them to study the eff... women that can lead to hypertension and heart fai... of Medicine // have created a better research rat...olved in hypertension. These rats will allow them ...
...iversity in New York are under investigation for a...esearch studies and filing false information on pr...th (NIH) to maintain government funding for a univ...cher at the pediatric center accused the center’s ...
...logical levels free radicals and antioxidants in d...ell established following our improved understandi...ential scope because of the fact that confirmation...that treatment for such disorders can be made very...
Other Medicine News:Health News:Protection against Alzheimer’s could be as simple as drinking green te 2
(Date:10/7/2008)...ss., Oct. 7 /- Taligen Therapeutics I...f the Company,s pipeline,candidates were presented...Basel, Switzerland. The data highlighted the candi...ment-mediated diseases., "These highlighted prese...ented at the conference, reveal the deep expertise...
(Date:10/7/2008)...pective Randomized Placebo-Controlled Phase II Stu...ed Overall Survival., MOUNTAIN VIEW, California, ...s now evaluated the mature Phase II data from the,...TVAC(TM) that had been,obtained as part of the rec... Institute (NCI) in the US., The results from the...
(Date:10/7/2008)...nded to Eight On-Demand Tests for Use on the GeneX...UNNYVALE, Calif., Oct. 7 /-...e of Xpert(TM) vanA/vanB as a European CE,IVD Mark...Diagnostic,Medical Devices. The test delivers rapi...ost commonly associated with vancomycin-resistant,...
(Date:10/6/2008)...J., Oct. 6 /- Pharmasset, I...mith, Ph.D., is joining the,Company as Vice Presid...ions. Dr. Smith will be responsible for all invest... Chief Financial Officer Kurt,Leutzinger., Most r... Biotechnology,Analyst at JPMorgan Securities, and...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3ImaRx Schedules Release of First Quarter 2008 Financial Results 5198 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 2Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 3MIT study suggests caution on new anti obesity drug in kids 18717 1MIT study suggests caution on new anti obesity drug in kids 18717 2Patients with chronic illness benefit from telehealth intervention 18715 1Patients with chronic illness benefit from telehealth intervention 18715 2
...ESS WIRE)--Jun 19, 2007 - Geron,Corporation (Nasda...the scalable production, survival following engraf...nfarcted rats was presented,today for GRNCM1, the ...herapeutic for heart failure, at the International...ting in Cairns,Australia., The presentation was o...
...ne 19, 2007 /PRNewswire-FirstCall/ --,Genaera Corp...ter,on trodusquemine (MSI-1436), its novel anti-ob...iation (ADA) 67th Scientific,Sessions, June 22 to ..., "Trodusquemine is a Multiple,Pathway Inhibitor t...sity, and Improves Plasma Insulin and Leptin Level...
Other Medicine Technology:Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 3Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 4Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 5Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 6Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant.
Intermittent catheter
Intermittent catheter
Medicine Products: